Readmission Risk in Chronic Obstructive Pulmonary Disease Patients: Comparative Study of Nebulized Β2-Agonists

Drugs - Real World Outcomes - Switzerland
doi 10.1007/s40801-016-0097-y
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Assessment of Spirometry Testing and Inpatient Readmission in Patients With Chronic Obstructive Pulmonary Disease

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Comparative Study of Personality of Patients With Chronic Obstructive Pulmonary Disease by GOLD Stage

Japanese Journal of Health Promotion and Physical Therapy
2019English

Cardiovascular Risk in Chronic Obstructive Pulmonary Disease

Circulation Journal
MedicineCardiovascular MedicineCardiology
2014English

Study of OSA in Chronic Obstructive Pulmonary Disease

Journal of Medical Science And clinical Research
2017English

Prospective Risk of Osteoporotic Fractures in Patients With Advanced Chronic Obstructive Pulmonary Disease

Chronic Respiratory Disease
PulmonaryRespiratory Medicine
2018English

Nutritional Evaluation in Chronic Obstructive Pulmonary Disease Patients

Pakistan Journal of Biological Sciences
AgronomyCrop Science
2012English

Serum Biomarkers in Patients With Stable and Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Comparative Study

Journal of Medical Biochemistry
BiochemistryClinical Biochemistry
2019English

Evaluation of Risk Factors Causing Osteoporosis in Chronic Obstructive Pulmonary Disease (COPD) Patients.

2019English

Рhysiotherapy in Patients With Chronic Obstructive Pulmonary Disease

Open Access Macedonian Journal of Medical Sciences
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy